業績一覧
ACHIEVEMENT LIST
-
Sato R, Kumai T, Kusaka T, Kano S, Ohkoshi A, Kubota S, Miyakura Y, Murayama K, Tagawa A, Godo S, Matsushita D, Tomizawa H, Toyoma S, Shirotori A, Takahara M: Treatment outcomes of primary salivary gland squamous cell carcinoma: A multi-institutional retrospective study in Japan
Auris Nasus Larynx. 52(1): 43-49, 2025
-
Watanabe T, Oka H, Nagashima K, Nishi H, Kumai Y, Iijima H, Okami K, Shimizu Y, Kano S, Ito K, Yamazaki T, Takahashi H, Oridate N, Yokota T, Koyama T, Kiyota N, Sato Y, Takahashi S, Kato K, Kadowaki S, Honma Y: Clinical outcomes of recurrent or metastatic head and neck cancer after failure of platinum and nivolumab: a multicenter retrospective study
Oncologist. 30(3): oyaf018, 2025
-
Miwa T, Fujiwara K, Matsuyoshi H, Nomura Y: Post-earthquake dizziness syndrome (PEDS): A comprehensive review of recent advances
Auris Nasus Larynx. 52(3): 253-257, 2025
-
Otsuka S, Morimoto C, Nishio SY, Morita S, Kikuchi D, Takahashi M, Kumakawa K, Arai Y, Sano H, Yoshimura H, Yamamoto N, Kondo S, Hasegawa M, Nishi T, Kitahara T, Usami SI: The Heterozygous p.A684V Variant in the WFS1 Gene Is a Mutational Hotspot Causing a Severe Hearing Loss Phenotype
Genes (Basel). 16(1): 57, 2025
-
Kagami K, Kitajima M, Watanabe H, Hamada T, Kobayashi Y, Kubo H, Oono S, Takai H, Ota S, Nagakura T, Onda T, Nagahori K, Sasaki N, Fujimoto I, Sato A, Sumikawa S, Matsui D, Ito Y, Baba M, Takeuchi T, Iwasaki S, Okubo T, Suzuki S, Kataoka S, Matsui Y, Inomata Y, Okada M, Sanmi H, Fukuda S, Wada N, Okada K, Niinuma Y, Ishiguro N: Association between confirmed COVID-19 cases at hospitals and SARS-CoV-2 levels in municipal wastewater during the pandemic and endemic phases
Environ Int. 197: 109342, 2025
-
Homma A, Ando M, Hanai N, Harada H, Honma Y, Kanda T, Kano S, Kawakita D, Kiyota N, Kizawa Y, Nakagawa M, Ogawa T, Shinomiya H, Shinozaki T, Suzuki M, Tsuji T, Yasuda K, Zenda S, Kodaira T, Kirita T, Nibu KI: Summary of Japanese clinical practice guidelines for head and neck cancer – 2022 update edited by the Japan society for head and neck cancer
Auris Nasus Larynx. 51(1): 174-188, 2024
-
Homma A, Mikami M, Matsuura K, Onimaru R, Yoshida D, Shinomiya H, Ohkoshi A, Hayashi R, Saito Y, Tachibana H, Shiga K, Ueda T, Uemura H, Nakamura K, Fukuda H: Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG): Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (JCOG1212): Results of the efficacy confirmation phase in patients with T4aN0M0: RADPLAT for T4aN0M0 Maxillary Sinus Cancer
Int J Radiat Oncol Biol Phys. 118(5): 1271-1281, 2024
-
Nakamaru Y, Suzuki M, Shizuki K, Honma A, Nakazono A, Kimura S, Watanabe R, Kano S, Tsushima N, Suzuki T, Homma A: Long-term results of nasolacrimal duct and inferior turbinate swing technique for inverted papilloma of the maxillary sinus
SAGE Open Med. 12:1-7, 2024
-
Fujiwara K, Morita S, Fukuda A, Hoshino K, Kobayashi M, Nakamaru Y, Furuta Y, Homma A: Evaluation of quality of life for patients with resolved facial nerve palsy
Auris Nasus Larynx. 51(3): 456-459, 2024
-
Fujiwara K, Morita S, Motegi H, Yamaguchi S, Ishi Y, Hoshino K, Fukuda A, Kobayashi M, Nakamaru Y, Fujimura M, Homma A: Pre- and post-operative semicircular canal function evaluated by video Head Impulse Test in patients with vestibular schwannoma
Auris Nasus Larynx. 51(3):542-547, 2024